Our study uncovers a novel mechanism by which NEURL3 promotes Vimentin degradation to inhibit NPC metastasis (Fig. 7j), thereby providing a promising therapeutic target for NPC treatment. This evidence concerns the gene VIM and nasopharyngeal carcinoma.